Salubres Formulations Private Limited
About Salubres Formulations Private Limited
Data last updated:
Salubres Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 18 March 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U52311TG2004PTC042889. Its GSTIN is 36AAICS8143F1Z7 (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹18.24 Lakh. It is led by directors Ramachandra Murthy Adivi (Managing Director) and Adivi Suseela.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 7 – 1 – 282/C/11 Pala Manor Aravind Nagar Colony B.K.Guda Balkampet, Hyderabad, Telangana, India – 500038.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.98 Lakh, a decline of 56% compared to the previous year. For the same year it recorded a net loss of ₹34.94 Lakh (net margin -53.8%) and EBITDA of -₹29.43 Lakh (EBITDA margin -45.3%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years and 17% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address7 – 1 – 282/C/11 Pala Manor Aravind Nagar Colony B.K.Guda Balkampet, Hyderabad, Telangana, India – 500038
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Salubres Formulations Private Limited
The main business activity of Salubres Formulations is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Salubres Formulations Private Limited FY 2025 filings available
Salubres Formulations Private Limited reported revenue of ₹64.98 Lakh (down 56% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Salubres Formulations Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 17% over five years, including a 56% fall in the latest year. EBITDA fell 174% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Salubres Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹29.43 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹34.94 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Salubres Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -45.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -53.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Salubres Formulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Salubres Formulations Private Limited
Salubres Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kancare Pharmaceuticals Private Limited | ₹65.29 Lakh (FY 2023) | •••• | •••• | 1596.0% | •••• | Roorkee, Uttarakhand, India |
| Hindustan Pharmatech Private Limited | ₹65.21 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Mumbai, Maharashtra, India |
| Kamalsons Pharma Private Limited | ₹65.17 Lakh (FY 2025) | •••• | •••• | 1019.0% | •••• | Aurangabad, Maharashtra, India |
| JH Herbo Shine Private Limited | ₹65.09 Lakh (FY 2025) | •••• | •••• | 204.0% | •••• | Lohardaga, Jharkhand, India |
| Lucis Pharmaceutical Private Limited | ₹64.98 Lakh (FY 2025) | •••• | •••• | -28.0% | •••• | Kolkata, West Bengal, India |
| Salubres Formulations Private Limited this company | ₹64.98 Lakh (FY 2025) | •••• | •••• | -56.0% | •••• | Hyderabad, Telangana, India |
| Varick Remedies Private Limited | ₹64.74 Lakh (FY 2018) | •••• | •••• | 43.0% | •••• | Secunderabad, Telangana, India |
| Beopt Biotech Private Limited | ₹64.64 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Patna, Bihar, India |
| Viswasoorya Pharmaceuticals Private Limited | ₹64.59 Lakh (FY 2025) | •••• | •••• | 91.0% | •••• | Chennai, Tamil Nadu, India |
| Medomed Life Science Private Limited | ₹64.57 Lakh (FY 2025) | •••• | •••• | -27.0% | •••• | Kollam, Kerala, India |
| Teyot Healthcare Private Limited | ₹64.52 Lakh (FY 2024) | •••• | •••• | 12.0% | •••• | Melmuri, Kerala, India |
Peers are the five companies nearest above and the five nearest below Salubres Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Salubres Formulations Private Limited
Salubres Formulations Private Limited is audited by G.V.RANGABABU for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G.V.RANGABABU | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Salubres Formulations Private Limited
Salubres Formulations has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Adivi Suseela | Director | 26 Mar 2008 | 18 Years 6 Months | Current |
| Ramachandra Murthy Adivi | Managing Director | 18 Mar 2004 | 22 Years 6 Months | Current |
Ownership and Shareholding of Salubres Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Salubres Formulations Private Limited
Salubres Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Salubres Formulations Private Limited
Employment history and EPFO contributions of people linked to Salubres Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Salubres Formulations Private Limited
Salubres Formulations has one previous CIN (Corporate Identification Number): U52311AP2004PTC042889. The current CIN is U52311TG2004PTC042889, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U52311TG2004PTC042889 | Current |
| U52311AP2004PTC042889 | Previous |
Recent Activity on Salubres Formulations Private Limited
Salubres Formulations Private Limited has 6 board changes on record since 2004: 2 appointments and 4 cessations. The latest: Ramachandra Murthy Adivi ceased to be Director on 14 Feb 2014.
Credit Ratings, Litigation & Regulatory Alerts for Salubres Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Salubres Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Salubres Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Salubres Formulations Private Limited
Salubres Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICS8143F1Z7 | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Salubres Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Salubres Formulations Private Limited
Salubres Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in chemical products, within the chemicals industry. It was incorporated on 18 March 2004 (22+ years old) and is registered under CIN U52311TG2004PTC042889.
Salubres Formulations reported revenue of ₹64.98 Lakh for FY 2025 (down 56% YoY).
Salubres Formulations has 2 current directors:
- Ramachandra Murthy Adivi - Managing Director
- Adivi Suseela - Director
Salubres Formulations reported a net loss of ₹34.94 Lakh (net margin -53.8%) and EBITDA of -₹29.43 Lakh (EBITDA margin -45.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Salubres Formulations is -25% over three years and -17% over five years. In the latest year (FY 2025) revenue fell 56%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Salubres Formulations is 36AAICS8143F1Z7, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Salubres Formulations is U52311TG2004PTC042889. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Salubres Formulations was incorporated on 18 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Salubres Formulations by revenue are Kancare Pharmaceuticals Private Limited, Hindustan Pharmatech Private Limited, Kamalsons Pharma Private Limited, JH Herbo Shine Private Limited, Lucis Pharmaceutical Private Limited and 5 more, all in the Pharma industry (Formulations).
Ramachandra Murthy Adivi ceased to be Director on 14 Feb 2014. Kolachala Radhakrishna ceased to be Director on 28 Mar 2008. Sri Vidya Gadiyaram ceased to be Director on 28 Mar 2008. Salubres Formulations has 6 board changes on record in total.
The registered office of Salubres Formulations is at 7 – 1 – 282C11 Pala Manor Aravind Nagar Colony B.K.Guda Balkampet, Hyderabad, Telangana, India – 500038.